Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

A new fluorescence/PET probe for intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated antibody

Kyung Oh Jung, Hyewon Youn, Mi Jeong Kim, Keon Wook Kang, Dong Soo Lee and June-Key Chung
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 276;
Kyung Oh Jung
2Biomedical Sciences, Seoul National University, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyewon Youn
5Cancer Imaging Center, Seoul National University, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mi Jeong Kim
1Department of Nuclear Medicine, Seoul National University, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keon Wook Kang
3Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dong Soo Lee
6Molecular Medicine and Biopharmaceutical Sciences, WCU Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
June-Key Chung
4Tumor Microenvironment Global Core Research Center, Seoul National University, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

276

Objectives Current antibody-based imaging probes cannot provide successful images for intracellular proteins in vivo. Human Telemorase Reverse Transcriptase (hTERT) is an excellent intracellular target because of its high expression in most cancers. In this study, we developed a new probe for optical and nuclear imaging to visualize intracellular hTERT.

Methods Monoclonal antibodies for hTERT were conjugated with the Tat peptide, fluorescence dye (FPR648) and 64Cu-NOTA. HT29 (hTERT+) and U2OS (hTERT-) cells were used for this experiments. In vitro fluorescence signals were imaged by confocal microscopy and live cell imaging, and analyzed by Tissue-FAXS. In vivo mice xenografts, tumors were visualized using Maestro and PETBOX.

Results Cellular penetration was improved by Tat peptide, and retention time was prolonged by binding of hTERT and its antibody in this probe. The fluorescence signals were clearly detected in HT29 cells after 24 hr. Strong positive fluorescence signal was observed in 78.54% of total cell population. Interestingly, this probe could visualize nuclear transport of hTERT after radiation which is blocked by Akt inhibitor. In vivo fluorescence and PET imaging clearly showed hTERT signals in HT29 tumors.

Conclusions We developed a new fluorescence/PET probe for visualizing the intracellular hTERT using the Tat conjugated antibody. This system can be applied to visualize other intracellular proteins for in vitro and in vivo imaging.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A new fluorescence/PET probe for intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated antibody
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A new fluorescence/PET probe for intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated antibody
Kyung Oh Jung, Hyewon Youn, Mi Jeong Kim, Keon Wook Kang, Dong Soo Lee, June-Key Chung
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 276;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A new fluorescence/PET probe for intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated antibody
Kyung Oh Jung, Hyewon Youn, Mi Jeong Kim, Keon Wook Kang, Dong Soo Lee, June-Key Chung
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 276;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • A general 11C-carboxylation approach mediated by fluoride-desilylation of organosilanes
  • Relationships between tau, atrophy, regional brain activity and connectivity in Alzheimer's disease: a PET/MRI multimodal study
  • Gray matter structural networks related to 18F-THK5351 retention in cognitively normal older adults and early Alzheimer’s disease patients
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Antibody, Nanoparticle and Cell-Based Oncology Probes

  • Preclinical evaluation of anti-αvβ6 diabodies and anti-αvβ6 cys-diabodies for imaging αvβ6-positive tumors with positron emission tomography
  • PET of follicle-stimulating hormone receptor: Broadly applicable for imaging of cancer
  • 111In-anti-F4/80 for in vivo tracking of tumor associated macrophages
Show more Antibody, Nanoparticle and Cell-Based Oncology Probes

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire